🇺🇸 FDA
Patent

US 7148323

Major neutralization site of hepatitis E virus and use of this neutralization site in methods of vaccination and in methods of screening for neutralizing antibodies to hepatitis E virus

granted A61KA61K2039/505A61K2039/53

Quick answer

US patent 7148323 (Major neutralization site of hepatitis E virus and use of this neutralization site in methods of vaccination and in methods of screening for neutralizing antibodies to hepatitis E virus) held by The United States of America, as represented by the Department of Health and Human Services expires Mon Dec 07 2026 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Department of Health and Human Services
Grant date
Tue Dec 12 2006 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 07 2026 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
6
CPC classes
A61K, A61K2039/505, A61K2039/53, A61K38/00, A61K39/00